retatrutide fatty liver disease nonalcoholic nash trial Trial comparing time-restricted eating (TRE) vs. basic Calorie STUDY: Novel “Triagonist” Retatrutide Resolved

[PMC free article: PMC4899165] [PubMed: 26718910] (Review of the concept of chemoprevention of cancer and the evidence that ashwagandha might be effective based upon in vivo studies of apoptosis, angiogenesis, stress response, inflammation, and cancer prevention in animal models)

Bartolini, D

OAT Results (selected abnormal findings): Elevated fumaric acid and citric acid (mitochondrial dysfunction) High pyroglutamic acid (glutathione depletion) Elevated arabinose (yeast overgrowth) Elevated methylmalonate (B12 deficiency) Elevated oxalic acid (possible gut or metabolic stress) Interpretation and Plan: Mitochondrial Support: Added L-carnitine, CoQ10 to support cellular energy

Ozempic, a GLP-1 receptor agonist used for diabetes management and weight loss, can exacerbate or contribute to the development of gastroparesis due to its effects on slowing gastric emptying